Universe Pharmaceuticals INC

NasdaqCM:UPC Stock Report

Market Cap: US$2.9m

Universe Pharmaceuticals Balance Sheet Health

Financial Health criteria checks 3/6

Universe Pharmaceuticals has a total shareholder equity of $26.7M and total debt of $6.5M, which brings its debt-to-equity ratio to 24.3%. Its total assets and total liabilities are $49.4M and $22.7M respectively.

Key information

24.3%

Debt to equity ratio

US$6.51m

Debt

Interest coverage ration/a
CashUS$11.39m
EquityUS$26.74m
Total liabilitiesUS$22.69m
Total assetsUS$49.43m

Recent financial health updates

Recent updates

Universe Pharmaceuticals INC (NASDAQ:UPC) Not Doing Enough For Some Investors As Its Shares Slump 44%

Nov 14
Universe Pharmaceuticals INC (NASDAQ:UPC) Not Doing Enough For Some Investors As Its Shares Slump 44%

Why Investors Shouldn't Be Surprised By Universe Pharmaceuticals INC's (NASDAQ:UPC) 92% Share Price Plunge

Sep 27
Why Investors Shouldn't Be Surprised By Universe Pharmaceuticals INC's (NASDAQ:UPC) 92% Share Price Plunge

Universe Pharmaceuticals INC's (NASDAQ:UPC) 41% Price Boost Is Out Of Tune With Revenues

Jul 22
Universe Pharmaceuticals INC's (NASDAQ:UPC) 41% Price Boost Is Out Of Tune With Revenues

Universe Pharmaceuticals INC's (NASDAQ:UPC) Price Is Right But Growth Is Lacking After Shares Rocket 31%

May 22
Universe Pharmaceuticals INC's (NASDAQ:UPC) Price Is Right But Growth Is Lacking After Shares Rocket 31%

Universe Pharmaceuticals INC's (NASDAQ:UPC) Shares Bounce 27% But Its Business Still Trails The Industry

Apr 07
Universe Pharmaceuticals INC's (NASDAQ:UPC) Shares Bounce 27% But Its Business Still Trails The Industry

Investors Don't See Light At End Of Universe Pharmaceuticals INC's (NASDAQ:UPC) Tunnel And Push Stock Down 27%

Feb 07
Investors Don't See Light At End Of Universe Pharmaceuticals INC's (NASDAQ:UPC) Tunnel And Push Stock Down 27%

There's No Escaping Universe Pharmaceuticals INC's (NASDAQ:UPC) Muted Revenues Despite A 54% Share Price Rise

Dec 18
There's No Escaping Universe Pharmaceuticals INC's (NASDAQ:UPC) Muted Revenues Despite A 54% Share Price Rise

Universe pharmaceuticals receives Nasdaq notification regarding minimum bid price deficiency

Jul 19

Improved Earnings Required Before Universe Pharmaceuticals INC (NASDAQ:UPC) Shares Find Their Feet

Feb 21
Improved Earnings Required Before Universe Pharmaceuticals INC (NASDAQ:UPC) Shares Find Their Feet

We Think That There Are Some Issues For Universe Pharmaceuticals (NASDAQ:UPC) Beyond Its Promising Earnings

Aug 10
We Think That There Are Some Issues For Universe Pharmaceuticals (NASDAQ:UPC) Beyond Its Promising Earnings

Financial Position Analysis

Short Term Liabilities: UPC's short term assets ($33.5M) exceed its short term liabilities ($20.6M).

Long Term Liabilities: UPC's short term assets ($33.5M) exceed its long term liabilities ($2.1M).


Debt to Equity History and Analysis

Debt Level: UPC has more cash than its total debt.

Reducing Debt: UPC's debt to equity ratio has increased from 23.3% to 24.3% over the past 5 years.

Debt Coverage: UPC's operating cash flow is negative, therefore debt is not well covered.

Interest Coverage: Insufficient data to determine if UPC's interest payments on its debt are well covered by EBIT.


Balance Sheet


Discover healthy companies